Hula Therapeutics is an immunotherapy company spinout from the lab of Dr, John Maris at Children’s Hospital of Philadelphia (CHOP). Hula is leveraging deep expertise to identify unique, functionally relevant, and essential tumor specific targets and make them accessible to precision therapeutics (e.g. cell therapy, T-cell engagers, bi-specifics, antibody drug conjugates) for the treatment of adults and children with solid cancers.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Philadelphia, Pa, Us
- Industry
- Biotechnology
- Website
- http://www.hulatx.com
- Keywords
- Immuno-oncology.
- HQ
- Philadelphia, PA
Hula Therapeutics Questions
Hula Therapeutics's website is http://www.hulatx.com
Hula Therapeutics's LinkedIn profile is https://www.linkedin.com/company/hulatx
Hula Therapeutics has
6 employees.
View email and phone details for 6
employees at Hula Therapeutics.
Hula Therapeutics's industry is
Biotechnology
Hula Therapeutics's top competitors are
Eliksa Therapeutics,
Spirovant Sciences, Inc.,
Carisma Therapeutics,
Strados Labs,
Thirdlaw Molecular,
Stealth Mode Biotech,
Verismo Therapeutics,
Kineticos Life Sciences,
Nabriva Therapeutics Plc,
Tantigen Bio.
Hula Therapeutics's categories are Biotechnology
Hula Therapeutics's founding year is 2022
